Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment

Author:

Kang Ting,Zhu Qianqian,Jiang Di,Feng Xingye,Feng Jingxian,Jiang Tianze,Yao Jianhui,Jing Yixian,Song Qingxiang,Jiang Xinguo,Gao Xiaoling,Chen Jun

Funder

National Key Basic Research Program

National Natural Science Foundation of China

Shanghai Science and Technology Committee

Program for New Century Excellent Talents in University

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference35 articles.

1. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation;Wang;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2006

2. Gliomatosis cerebri: no evidence for a separate brain tumor entity;Herrlinger;Acta Neuropathol.,2016

3. Engineered nanoparticles for drug delivery in cancer therapy;Sun;Angew. Chem. Int. Ed Engl.,2014

4. Tumor delivery of macromolecular drugs based on the EPR effect;Torchilin;Adv. Drug Deliv. Rev.,2011

5. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles;Xin;Biomaterials,2012

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3